comparemela.com
Home
Live Updates
Aptamer Sciences Inc. Files IND Application for Innovative Liver Cancer Treatment AST-201: A Promising Approach to Address Under Medical Needs : comparemela.com
Aptamer Sciences Inc. Files IND Application for Innovative Liver Cancer Treatment AST-201: A Promising Approach to Address Under Medical Needs
/PRNewswire/ -- Aptamer Sciences Inc. (KOSDAQ, 291650) announced the filing of an Investigational New Drug (IND) application for the phase 1 clinical trial of...
Related Keywords
Seongnam ,
Kyonggi Do ,
South Korea ,
Han ,
Hong Jae Chon ,
Aprc Aptamer Radioligand ,
National Cancer Center ,
Aptamer Sciences Inc ,
Bundang Medical Center ,
Samsung Medical Center ,
Korean Ministry Of Food ,
Aptamer Sciences ,
Investigational New Drug ,
Korean Ministry ,
Drug Safety ,
Aptamer Drug Conjugate ,
East Asia ,
Nature Medicine ,
Medical Center ,
Severance Hospital ,
Aptamer Radioligand Conjugate ,
Aptamer Immune Stimulator Conjugate ,
Dong Il Han ,
Sciences Inc ,
comparemela.com © 2020. All Rights Reserved.